Development of a novel immune infiltration-based gene signature to predict prognosis and immunotherapy response of a novel anti-PD-L1/TGF-β bifunctional fusion protein in recurrent cervical cancer

The hypothesis-generating case study aimed at identifying those who are sensitive to anti-PD-L1 and TGF-β bifunctional fusion proteins and exploring potential mechanisms in the treatment of recurrent cervical cancer. We report that recurrent cervical cancer treated with anti-PD-L1 and TGF-β bifuncti...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yucen Mao, Naidong Xing, Wenxiong Sun, Xinyue Bao, Xihan Liu, Richao Wu, Jin Peng
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2026-12-01
coleção:	Human Vaccines & Immunotherapeutics
Assuntos:	Recurrent cervical cancer anti-PD-L1/TGF-βRII bifunctional fusion protein tumor immunotherapy
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/21645515.2026.2647560
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!